Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
ACE, addiction, addressing, administer, aging, aid, aimed, alternative, analyzed, analyzing, annum, applied, apply, assist, beta, BRAF, Caliper, CardioPredict, category, cf, cfDNA, channel, chronic, commonly, companion, concordance, copy, covenant, decide, delivery, DGX, dosing, Earlier, EGFR, employee, exhausted, explore, factor, fixed, foregoing, hand, highlight, identification, imminent, implicated, influence, inhibitor, introduced, LabChip, mediate, melanoma, metabolism, methadone, moderate, Nasdaq, NYSE, October, opioid, optimize, overdose, oxycodone, pain, PDI, PDII, PerkinElmer, PKI, plasma, platelet, portfolio, predict, pressure, primary, promotion, prospect, prospectively, public, purport, Quest, rare, relevance, relevant, represented, reserve, retrospectively, safety, scope, solution, strength, Subtopic, suffer, terminating, text, thinner, tool, toxicity, ultrasensitive, unequalled, warfarin
Filing tables
Filing exhibits
Related press release
PRPO similar filings
Filing view
External links